Activation of the thick ascending limb (TAL) Na
INTRODUCTION
Water conservation by the mammalian kidney is achieved by the tightly controlled, coordinate action of epithelial and vascular components. The hypothalamic antidiuretic hormone (arginine-vasopressin, AVP) plays a dominant role herein. It stimulates luminal insertion of water channels along the connecting tubule and collecting duct epithelia, and of urea transporters into medullary portion of the collecting duct (37).
The thick ascending limb (TAL) is sensitive to AVP as well, since abundance, phosphorylation, and surface expression of the furosemide sensitive Na While the regulation of 20-HETE and PGE2 during AVP-induced antidiuresis has been studied in considerable detail (59, 73, 77), less is known regarding the mechanisms which determine synthesis and metabolism of EET in this setting. EET exist as four regioisomers, 5,6-EET, 8,9-EET, 11,12-EET, and 14,15-EET which are synthesized by the cytochrome p450 (CYP450) monooxygenases (18, 57). CYP450 isoforms 2C9/10, 2C11, 2C23, 2J3, and 2J4 have all been shown to contribute to renal EET synthesis (18, 19, 34) . In rats, 2C23 is considered the principal renal isoform to generate EET in rat kidney (34) . EET are metabolically degraded mainly by soluble epoxide hydrolase (sEH) which hydrolyses EET to their corresponding, less active dihydroxyeicosatrienoic acid isomers (DHET) (31, 57). The preferred substrates for sEH are 14,15-EET, 11,12-EET, and 8,9-EET whereas the affinity of the enzyme towards 5,6-EET is low (30). The kidney shows substantial sEH activity, but the site of its synthesis and regulation within the renal parenchyma has not been univocally clarified (19, 33, 38, 48, 75). Earlier, microarray-based gene expression studies have provided evidence for AVP-dependent activation of sEH in the kidney (17, 51), prompting us to study the effects of AVP on renal medullary EET metabolism in greater detail.
In the present study, we found that sEH is abundantly expressed in the segments of human and rat nephrons and collecting duct system. Chronic AVP treatment induced sEH biosynthesis in AVP-deficient Brattleboro rats, which was associated with a reduction of renal EET levels. Functional studies in isolated TAL segments demonstrated an inhibitory effect of 14,15-EET on NKCC2 phosphorylation and transport activity. Induction of sEH by AVP may therefore be an essential mechanism for the maintenance of sustained antidiuresis.
MATERIALS AND METHODS
Animal studies and tissue preservation. Animal studies were performed according to NIH guidelines after approval by the Berlin council on animal care (permission numbers G006-02/05, G0285/10, and O0124/96). For localization studies adult Sprague Dawley (SD) rats (n = 3) were perfusion-fixed via the abdominal aorta using a fixative containing 3% paraformaldehyde (Merck, Darmstadt, Germany) dissolved in PBS as previously described (52). Kidneys were harvested and processed for cryostat and paraffin sectioning using established methodology (51). For Western blot analysis of zonal sEH distribution additional SD rats (n = 3) were killed by cervical dislocation. Kidneys were carefully removed and dissected into cortex, outer medulla and inner medulla using sterile razor blades and a stereotactic microscope. Samples were subsequently snap frozen in liquid nitrogen, and stored at -80°C until further use. Human kidney samples (n = 3) were obtained from the healthy parts of tumor nephrectomy specimen after written consent of the patients. Tissue blocks were immersion-fixed for 12 h using 3% paraformaldehyde in PBS and subsequently processed for paraffin embedding (46) . Animals were backcrossed into FVB/N background for at least 6 generations (28). At three month of age kidneys of male knockout and wild type mice (n = 4 for each genotype) were harvested for biochemical analysis or fixed overnight using 3% paraformaldehyde in PBS and processed for histological studies.
Microdissection of murine TAL segments was performed as previously described (9) using a total of 6 male C57/Bl6 mice (Charles River, Sulzfeld, Germany).
Microarray studies. Gene expression profiling studies were conducted in the microarray facility at the Zentrum für Medizinische Forschung of the University Mannheim (Mannheim, Germany) as previously described (17, 51). Affymetrix rat genome 230 2.0 arrays and a custom CDF version 9 annotation with Unigene based gene definitions (http://brainarray.mbni.med.umich.edu/Brainarray/Database/CustomCDF/CDF_download_v9.asp) were used for the analysis. Raw and normalized data were deposited in the Gene Expression Omnibus database (http://www.ncbi.nlm.nih.gov/geo/; GEO accession number: GSE34225).
Quantification of renal outer medullary lipid levels. Free tissue lipid levels were determined by mass spectrometry in kidney samples of dDAVP treated Brattleboro rats and controls. Samples were powdered in liquid nitrogen, dissolved in a 50/50 v/v mixture of water/and methanol supplemented with 0,01% butylhydroxytoluol, mixed with 10 µL internal standard solution (0,5 µg/mL), andbuffered at pH 6 with 2 mL SPE-buffer (0.1 mol/L aqueous sodium acetat solution, pH 6). Solid-Phase-Extraction was performed using a Bond-Elut-Certify-II-Column (Phenomenex, Torrance, USA). Eicosanoids were eluted with 2 ml nhexan/ethylacetat (25/75 v/v) with 1% acetic acid. The solvent was evaporated with a gentle stream of N 2 at 40°C. Residues were resuspended in 100 µL methanol/water mixture and processed for measureing.
Liquid chromatography-mass spectrometry (LC-MS/MS) was performed at the mass spectrometry facility of Lipidomix GmbH as previously described (Lipidomix GmbH, Berlin, Germany) (2). Free tissue levels of EET isomers and of the linoleic acid epoxides 9,10-EPOME and 12,13-EPOME and their respective diols 9,10-DIHOME and 12,13-DIHOME were determined in parallel. Since the formation of these diols is also catalyzed by sEH the ratio of DIHOME and EPOME isomers can be utilized as measure for sEH tissue activity (20, 68).
Real time polymerase chain reaction (PCR)
. mRNA was isolated from whole kidney homogenates using Roti-Aqua phenol-chloroform extraction kit according to the manufacturer's protocol (Carl Roth, Karlsruhe, Germany). After digestion of genomic DNA by DNAse 1 treatment (Qiagen, Hilden, Germany) cDNA was generated by reverse transcription using the Applied Biosystems cDNA synthesis kit (Applied Biosystems, Darmstadt, Germany). TaqMan quantitative RT-PCR for sEH was performed using the Applied Biosystems probe Mm00514706 and the 7500 Fast Real-Time PCR system (Applied Biosystems) following the manufacturer's instructions. The mRNA levels of GAPDH were determined in parallel and served as loading control (catalogue number 4352338E, Applied Biosystems). Expression levels were calculated using the 2 -ΔΔCT method and expressed as % of control (40).
Primary antibodies. For detection of sEH we used an affinity purified rabbit antibody against human sEH (1:500, HPA023094, Atlas Antibodies, Stockholm, Sweden). Antibodies against total and phospho-(p)-T96/T101-NKCC2 were generated in our laboratory and have been described before (46) . Germany) and has been described before (3). Antibody against mouse alpha-smooth muscle actin was from DAKO (Hamburg, Germany); antibody for β-actin was from Sigma-Aldrich.
Immunoblotting. Samples for Western blotting were prepared as previously described (71). Briefly, tissues were ground in liquid nitrogen using sterile mortar and pestle and subsequently dissolved in homogenization buffer containing 250 mM sucrose, 10 mM triethanolamine, and protease inhibitors (cOmplete protease inhibitor cocktail, Roche Diagnostics, Indianapolis, USA). Nuclei were removed by centrifugation (1000 x g for 10 min). Protein concentration of post nuclear homogenates was determined using bicinchoninic acid protein assay following the manufacturer`s instructions (Thermo Fisher Scientific, Bonn, Germany). Samples were subsequently separated by SDS polyacrylamide gel electrophoresis in a 10% gel (50 µg protein/lane) and electrophoretically transferred to nitrocellulose membranes. Primary antibodies were applied after blocking of nonspecific protein binding sites with 5% non-fat dry milk in PBS.
Membranes were incubated for 1 h at room temperature followed by an overnight-incubation at 4° C.
Bound antibody was detected using the appropriate HRP-conjugated secondary antibodies and chemiluminescence. Developed X-ray films were scanned and densitometrically evaluated using the Alpha Imager software (Cell Biosciences, Santa Clara, USA). Expression levels were normalized to the expression of the housekeeping gene -actin.
Immunostaining. Immunofluorescence and immunoperoxidase staining were carried out as previously described (51). Briefly, 4 µm paraffin sections were deparaffinized, rehydrated and subjected to antigen retrieval by boiling in 0.1 M sodium citrate buffer using a pressure cooker. Non-specific binding sites were blocked by incubation with 5% dry milk in PBS. Renal localization of sEH was studied by immunofluorescence staining on 4 µm paraffin sections of human and rat kidneys using the rabbit anti sEH antibody in a 1:100 dilution. Immunoreactive nephron segments were characterized by double labeling with the established segment-specific antibodies to NKCC2 (1:5000 dilution) for TAL, COX-2
(1:100 dilution) for macula densa, NCC (1:100 dilution) for distal convoluted tubule, and AQP2 (1:100 dilution) for connecting tubule and collecting duct, respectively. Bound antibodies were detected with the appropriate Alexa488 or Cy3-labeled secondary antibodies (Dianova, Hamburg, Germany). Stained sections were examined by confocal microscopy using a Zeiss LSM Exciter confocal microscope and ZEN 2008 software (Carl Zeiss, Jena, Germany). Sections for immunoperoxidase staining were prepared as detailed above. Tissue peroxidases were blocked with 3% hydrogen peroxide in methanol prior to application of the primary antibodies. Signal was developed using HRP-labelled donkey anti rabbit secondary antibody (Dianova) and 3,3′-diaminobenzidine containing 0.3% hydrogen peroxide (SigmaAldrich); samples were processed synchronously with standardized incubation times to ensure comparability of the measurements.
Validation of sEH antibody. Antibody-specificity was verified by immunoblotting in sEH knockout tissue and by peptide blockade in rat kidney sections. To this end we performed Western blot on total kidney homogenates from sEH deficient mice and their respective controls. Peptide blockade studies were conducted using the immunizing peptide (APrEST76223, Atlas antibodies, Stockholm, Sweden). sEH antibody was diluted in 5% nonfat dry milk in PBS and incubated at 37° C for 30 minutes with different amounts of blocking peptide prior to application to rat kidney sections. Western blotting and immunostainings were performed as described above. Statistical analysis. All values are given as means ± SEM. Statistical analysis was performed using unpaired Student's t-test or ANOVA with post hoc Tukey´s test. Null hypothesis was excluded when P was < 0.05.
Renal

Results
Effect of dDAVP on medullary expression of EET-metabolizing enzymes. Screening of Affymetrix
microarray results from kidney extracts of dDAVP or vehicle treated Brattleboro rats revealed constant mRNA levels for the CYP monooxygenases in CYP2C11, CYP2C23, CYP2J3, and Cyp2J10 (Table 1) .
Abundance of CYP2J4 mRNA was reduced by 20% relative to the vehicle treated controls (p < .05) but subsequent real time PCR verification studies in a separate set of animals (n = 5 per group) failed to confirm differential regulation (data not shown). mRNA levels for sEH were significantly induced (+145% relative to controls; p < 0.05) and in the real time PCR verification studies (+160 ± 37%, p < 0.05). ng/g vs. 34.7 ± 9.2 ng/g; p < 0.05) relative to controls. Levels of the 8,9-isomer showed a strong trend towards reduced levels (17.4 ± 4 ng/g vs. 44 ± 13.4 ng/g; p = 0.08) but failed to reach the level of statistical significance. Values are given as ng EET/g wet tissue weight in dDAVP and vehicle treated animals with n = 7 to 8 animals per group (Fig. 1) . It must be noted that 5,6-EET rapidly forms a lactone in aqueous solutions which may differ from the parent molecule in its biological activity. During the tissue processing for our mass spectrometry assay this lactone is converted back to 5,6-EET. Thus, the measured levels for the 5,6-EET regioisomer may be higher than the biologically active levels in the tissue.
We also determined the levels of the linoleic acid epoxides 9,10-EPOME (69 ± 14 ng/g vs. 254 ± 60 ng/g; p < 0.05) and 12,13-EPOME (36 ± 11 ng/g vs. 166 ± 44 ng/g; p < 0.05) as well as their respective diols 9,10-DIHOME (52 ± 8.8 ng/g vs. 47 ± 8.7 ng/g; p = 0.7 n.s.) and 12,13-DIHOME (85 ± 25 ng/g vs. 56
± 14 ng/g; p = 0.4 n.s.) in dDAVP-treated Brattleboro rats and controls. The ratios for 9,10-DIHOME and 9,10-EPOME (0.85 vs. 0.23; n = 7 to 8 animals per group; p < 0.05) and 12,13-DIHOME and 12,13-EPOME (2.54 vs. 0.43; n = 7 to 8 animals per group; p < 0.01) were significantly increased in the dDAVPtreated animals thus demonstrating increased sEH enzyme activity (Fig. 2) .
Characterization of sEH antibody. Specificity of the sEH antibody was verified by peptide blockade and by immunoblotting on kidney samples of sEH deficient mice. Preincubation of sEH antibody with the immunizing peptide caused a dose-dependent decrease in signal intensity in rat kidney sections. Blockade was maximal at ten-fold excess of the blocking peptide (Fig. 3A) . Western blot analysis of kidney homogenates from wild type mice revealed the presence of a dominant sEH-immunoreactive band at 63 kDa which was absent in the homogenates of the sEH deficient mice. An additional band was detected at 70 kDa. However, this band was also present in the sEH-deficient mice and was therefore considered unspecific ( Fig. 3B ).
Renal distribution of sEH. Zonal distribution of sEH was analyzed on rat kidney homogenates isolated from cortex and outer and inner medulla. Distribution of NKCC2 was determined in parallel and showed abundant signal in the outer medulla, weaker signal in the cortex and absence of signal in the inner medulla thus confirming the adequate separation of the kidney zones. Western blot for sEH revealed a dominant immunoreactive band at approximately 63 kDa which was present in all kidney zones. Samples from the inner medulla contained additional sEH-immunoreactive products at 50 and 48 kDa which probably represent splice variants of the enzyme (Fig. 3C) (27) .
Immunofluorescence labeling of rat and human kidney sections confirmed abundant expression of immunoreactive protein in all kidney zones (Figures 3-6 ). In the cortex strong cytosolic sEH signal was found in profiles of the macula densa as indicated by the coexpression COX-2 ( Fig. 4A-C) . Coexpression of sEH and COX-2 was further detected in a subset of cells in the cortical TAL (Fig. 4D-F (Fig. 5A-C) . Profiles of the thin ascending limb of the loop of Henle stained positive as well (Fig. 5D-F) . Strong staining for sEH in the outer medulla was further detected in the collecting ducts which were typically in close proximity with NKCC2 expressing profiles of the thick ascending limb thus suggesting functional interaction (Fig. 5G-I) . Staining in the inner medulla was localized to tDLH, tALH, and to the principal cells of the inner medullary collecting duct as indicated by the coexpression of AQP2 (Fig. 5J-L) . Since immunohistochemistry does not allow the distinction between the full-length protein and the shorter products, the observed signals in the inner medulla reflect the sum of the full-length protein and the shorter variants.
The renal vasculature, as identified by the expression of alpha smooth muscle actin in myocytes and pericytes of the vascular wall, was devoid of sEH staining (Fig. 6 ). Studies in human kidney samples confirmed the expression in the macula densa and in the collecting duct using the sEH antibody validated in rodent tissue together with NKCC2 or AQP2 co-staining (Fig. 7) .
Effect of chronic dDAVP treatment on renal sEH expression. The effects of a chronic activation of the urine concentrating mechanism on renal sEH expression were studied in dDAVP-treated Brattleboro rats. Functional data for these animals demonstrating augmented urine concentration and induced levels of NKCC2 and aquaporin 2 have been reported before (17, 51). Immnuohistochemistry revealed icreased sEH protein levels in the cortex and in the outer medulla of dDAVP-treated animals. Here sEH signal was strongly increased in connecting tubules and in the cortical and outer medullary collecting ducts. Protein levels in the inner medulla remained unchanged (Fig. 8A) . Western blot analysis of total kidney homogenates confirmed increased levels of the 63 kDa (+65 ± 7% compared to controls; p < 0.05) and the 50 kDa (+65 ± 7% compared to controls; p < 0.05) variant of the protein in the dDAVP treated animals ( Figure 8B-C) .
Effect of EET regioisomers on TAL transport activity and NKCC2 phosphorylation. The acute effects of the different EET regioisomers on the phosphorylation of NKCC2 were determined in murine kidney cell suspensions pre-stimulated with 100 nM dDAVP. Incubation of these cell suspensions with the individual EET regioisomers resulted in a significant reduction of pNKCC2 abundance for 5,6-EET, 8,9-EET and 14,15-EET when compared to the vehicle-treated controls (-35 ± 14%, -53 ± 8%, and -66 ± 5%, respectively; p < 0.05). In contrast, 11,12-EET had no effect (+18 ± 15%, p = 0.5) (Fig. 9) . To corroborate these results we studied the effects of the 14,15-EET regioisomer in greater detail and also included the inactive metabolite 14,15-DHET. Phosphorylation of NKCC2 functionally changes the transport current by changing NKCC2 membrane trafficking as well as by changing its Cl -affinity, rate-limiting in the cortical TAL with already dilute luminal fluid (9, 22) . To investigate the effect of 14,15-EET on TAL tubular transport we therefore measured the equivalent short circuit current I' sc under two Cl -concentrations, at 147 mmol/l to as assess maximal transport velocity ("V max" ) of the transporter and at 30 mmol/l, a concentration close to the described EC50 of NKCC2 for Cl - (22) . ( Fig.10 A) . To address the question if 14,15-EET only reduces the total amount of NKCC2 in the plasma membrane, thereby shifting the curve in the scheme (Fig. 10 B ) from 1 to 2, or also decreases its Claffinity (curve 3 in the scheme) we calculated the percentage of I'sc (low Cl-) of the respective "V max " (147 Cl-) values (Fig. 10 B) . 14,15-EET treatment led to a 55% reduction indicating a markedly reduced Claffinity. In contrast, pretreatment with 14,15-DHET did not induce a change in any of the parameters.
Treatment of murine kidney cell suspensions with100 nM dDAVP and 14,15-EET at concentrations of 0.1 or 1 µM resulted in a dose-dependent reduction of pNKCC2 levels when compared to cell suspensions treated with 100 nM dDAVP and ethanol as vehicle (control). Treatment with 1 µM 14,15-DHET had no effect on the NKCC2 phosphorylation (Fig. 10D) .
Effect of sEH gene disruption on NKCC2 phosphorylation. Analysis of outer medullary pNKCC2
abundance revealed greatly reduced levels in the sEH-deficient mice relative to the wild type controls ( Figure 11 ) whereas total NKCC2 abundance was unchanged (data not shown).
DISCUSSION
Aim of the present study was to characterize the effects of AVP on the abundance and metabolism of EET isomers in the kidney. We have demonstrated markedly reduced tissue levels of EET isomers along with an increased abundance of the principal EET-metabolizing enzyme sEH in connecting tubules and collecting ducts of AVP-treated Brattleboro rat kidneys as compared to vehicle treated controls. EET isomers and AVP have been shown to exert opposing effects on essential renal sodium transporters. In CNT and CD, AVP activated the amiloride-sensitive epithelial sodium channel ENaC (5, 6), whereas 14,15-EET acted as potent inhibitor of ENaC transport activity (13). In the TAL, AVP caused activation of NKCC2-dependent ion transport in part by increasing its phosphorylation (46) . In the present study we Based on our findings we thus suggest that the detrimental effects of AVP may in part be mediated by its effect on sEH synthesis and the resulting accelerated degradation of vasodilatory and transport-inhibiting EET.
In summary, we have shown that activation of AVP signaling causes upregulation of renal sEH biosynthesis and enzyme activity. The resulting reduction of EET tissue levels may facilitate increased transport activity and renal vasoconstriction to promote antidiuresis, but it may as well render the kidney susceptible to insult. Further characterization of the AVP-sEH-EET axis may therefore provide new targets for renoprotective therapeutic strategies.
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Figure 11. Effect of sEH deficiency on outer medullary levels of phosphorylated NKCC2 (pNKCC2).
Representative low (I,II) and high (III,IV) power micrographs showing reduced levels of immunoreactive pNKCC2 in the outer medulla of sEH deficient mice (II,IV; sEH -/-) compared to wild type controls (I,II).
Immunoperoxidase staining; bars 200 µm for I, II, and 20 µm for III, IV. n = 4 per group. 
